AP2627A - New form of administration of racecadotril - Google Patents

New form of administration of racecadotril

Info

Publication number
AP2627A
AP2627A AP2008004686A AP2008004686A AP2627A AP 2627 A AP2627 A AP 2627A AP 2008004686 A AP2008004686 A AP 2008004686A AP 2008004686 A AP2008004686 A AP 2008004686A AP 2627 A AP2627 A AP 2627A
Authority
AP
ARIPO
Prior art keywords
racecadotril
administration
new form
new
Prior art date
Application number
AP2008004686A
Other languages
English (en)
Other versions
AP2008004686A0 (en
Inventor
Jean-Charles Schwartz
Jeanne-Marie Lecomte
Original Assignee
Bioprojet Soc Civ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37552919&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2627(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioprojet Soc Civ filed Critical Bioprojet Soc Civ
Publication of AP2008004686A0 publication Critical patent/AP2008004686A0/xx
Application granted granted Critical
Publication of AP2627A publication Critical patent/AP2627A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AP2008004686A 2006-05-15 2007-05-14 New form of administration of racecadotril AP2627A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0604302A FR2900823B1 (fr) 2006-05-15 2006-05-15 Nouvelle forme d'administration du racecadotril.
PCT/FR2007/000814 WO2007132091A1 (fr) 2006-05-15 2007-05-14 Nouvelle forme d'administration du racecadotril

Publications (2)

Publication Number Publication Date
AP2008004686A0 AP2008004686A0 (en) 2008-12-31
AP2627A true AP2627A (en) 2013-03-26

Family

ID=37552919

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2008004686A AP2627A (en) 2006-05-15 2007-05-14 New form of administration of racecadotril

Country Status (28)

Country Link
US (1) US8318203B2 (ko)
EP (1) EP2018158B1 (ko)
KR (1) KR101432116B1 (ko)
CN (2) CN103961328A (ko)
AP (1) AP2627A (ko)
AU (1) AU2007251471B2 (ko)
BR (1) BRPI0710405B8 (ko)
CA (1) CA2652023C (ko)
CY (1) CY1114190T1 (ko)
DK (1) DK2018158T3 (ko)
EA (1) EA014707B1 (ko)
EC (1) ECSP088889A (ko)
ES (1) ES2421929T3 (ko)
FR (1) FR2900823B1 (ko)
HR (1) HRP20130624T1 (ko)
IL (1) IL195270A (ko)
MA (1) MA30466B1 (ko)
MX (1) MX2008014554A (ko)
NO (1) NO342977B1 (ko)
NZ (1) NZ573424A (ko)
PL (1) PL2018158T3 (ko)
PT (1) PT2018158E (ko)
RS (1) RS52912B (ko)
SI (1) SI2018158T1 (ko)
TN (1) TNSN08428A1 (ko)
UA (1) UA98299C2 (ko)
WO (1) WO2007132091A1 (ko)
ZA (1) ZA200809721B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102018707A (zh) * 2010-11-29 2011-04-20 昆明邦宇制药有限公司 一种治疗腹泻的药物组合物及其制剂
CN102133186B (zh) * 2011-03-18 2012-08-01 海南美大制药有限公司 一种消旋卡多曲脂质体固体制剂
CN102166197B (zh) * 2011-04-25 2012-09-05 四川百利药业有限责任公司 消旋卡多曲颗粒及其生产工艺
JP2013180961A (ja) * 2012-02-29 2013-09-12 Astellas Pharma Inc Ｗｓ７２７７１３含有固形製剤
RU2632441C2 (ru) 2012-06-28 2017-10-04 МакНЕЙЛ-ППС, ИНК. Липидные композиции рацекадотрила
US9801819B2 (en) 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
TR201801726T4 (tr) * 2012-12-26 2018-03-21 Ilko Ilac Sanayi Veticaret A S Rasekadotri̇l ve farmasöti̇k bi̇leşi̇mleri̇.
CN105848643A (zh) * 2013-12-23 2016-08-10 强生消费者公司 消旋卡多曲组合物
EP2918268A1 (en) 2014-03-10 2015-09-16 Galenicum Health S.L. Pharmaceutical compositions comprising an active agent
ES2555484T1 (es) 2014-05-26 2016-01-04 Galenicum Health S.L. Composiciones farmacéuticas que contienen un agente activo
MA40859A (fr) 2014-10-29 2017-09-05 Johnson & Johnson Consumer Inc Particules de cadotril
EP3256107B1 (en) * 2015-02-09 2020-08-12 Rivopharm SA Pharmaceutical formulation of racecadotril
CN106822907B (zh) * 2016-12-29 2021-02-09 山东达因海洋生物制药股份有限公司 一种含消旋卡多曲的双相释放制剂及其制备方法
WO2018163195A1 (en) * 2017-03-06 2018-09-13 Athena Drug Delivery Solutions Pvt Ltd. A pharmaceutical composition comprising racecadotril and process for preparing the same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001097803A1 (en) * 2000-06-23 2001-12-27 Laboratoire Glaxosmithkline Pharmaceutical preparations comprising racecadotril (acetorphan)
WO2001097801A2 (en) * 2000-06-23 2001-12-27 Societe Civile Bioprojet Dry powder formulation comprising racecadotril
EP1563848A1 (en) * 2004-02-12 2005-08-17 Bioprojet New combinations of an anti-emetic agent and an enkephalinase inhibitor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4401677A (en) * 1981-10-09 1983-08-30 E. R. Squibb & Sons, Inc. Enkephalinase inhibitors
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
US20040253305A1 (en) * 2003-06-12 2004-12-16 Luner Paul E. Pharmaceutical compositions of atorvastatin
US20050027012A1 (en) * 2003-07-16 2005-02-03 Boehringer Ingelheim International Gmbh Tablets containing ambroxol
PL1789021T3 (pl) * 2004-08-13 2012-04-30 Boehringer Ingelheim Int Preparat tabletkowy o przedłużonym uwalnianiu zawierający pramipeksol lub jego farmaceutycznie dopuszczalną sól
US20070254050A1 (en) * 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001097803A1 (en) * 2000-06-23 2001-12-27 Laboratoire Glaxosmithkline Pharmaceutical preparations comprising racecadotril (acetorphan)
WO2001097801A2 (en) * 2000-06-23 2001-12-27 Societe Civile Bioprojet Dry powder formulation comprising racecadotril
EP1563848A1 (en) * 2004-02-12 2005-08-17 Bioprojet New combinations of an anti-emetic agent and an enkephalinase inhibitor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SANKAR, D. GOWRI ET AL: "Spectrophotometric determination of famciclovir and racecadotril" ASIAN JOURNAL OF CHEMISTRY, vol. 17, no. 3, 2005, pages 2043-2045, XP008073284 *

Also Published As

Publication number Publication date
RS52912B (en) 2014-02-28
EA200802324A1 (ru) 2009-04-28
WO2007132091A1 (fr) 2007-11-22
PT2018158E (pt) 2013-07-24
FR2900823B1 (fr) 2009-02-13
SI2018158T1 (sl) 2013-09-30
NO20084826L (no) 2008-12-12
EA014707B1 (ru) 2011-02-28
ES2421929T3 (es) 2013-09-06
IL195270A (en) 2016-08-31
AU2007251471B2 (en) 2012-03-15
US20090186084A1 (en) 2009-07-23
BRPI0710405B1 (pt) 2019-01-08
MA30466B1 (fr) 2009-06-01
MX2008014554A (es) 2008-11-27
DK2018158T3 (da) 2013-07-22
CN103961328A (zh) 2014-08-06
ECSP088889A (es) 2009-01-30
BRPI0710405B8 (pt) 2021-05-25
UA98299C2 (ru) 2012-05-10
US8318203B2 (en) 2012-11-27
HRP20130624T1 (en) 2013-08-31
CN101442990A (zh) 2009-05-27
CA2652023A1 (fr) 2007-11-22
IL195270A0 (en) 2009-08-03
BRPI0710405A2 (pt) 2011-08-09
KR101432116B1 (ko) 2014-08-21
CY1114190T1 (el) 2016-08-31
PL2018158T3 (pl) 2013-09-30
CA2652023C (fr) 2016-06-28
KR20090017593A (ko) 2009-02-18
NO342977B1 (no) 2018-09-17
EP2018158A1 (fr) 2009-01-28
EP2018158B1 (fr) 2013-04-24
FR2900823A1 (fr) 2007-11-16
ZA200809721B (en) 2009-06-24
AU2007251471A1 (en) 2007-11-22
NZ573424A (en) 2012-03-30
AP2008004686A0 (en) 2008-12-31
TNSN08428A1 (fr) 2010-04-14

Similar Documents

Publication Publication Date Title
AP2627A (en) New form of administration of racecadotril
HK1249031A1 (zh) 疫苗施用的方法
EP2101745A4 (en) DISTRIBUTION OF MEDICINAL PRODUCTS
ZA200900345B (en) Preparation of pharmaceutical formulations
EP2068864A4 (en) THERAPEUTIC USES OF UROLITHINS
HK1126975A1 (en) Pharmaceutical compositions with enhanced stability
EP2152274A4 (en) NASAL ADMINISTRATION OF BENZODIAZEPINES
SI2173345T1 (sl) Oralna formulacija metadoksina
IL196228A0 (en) 4-hydroxythiobenzamide derivatives of drugs
EP2001400A4 (en) ORAL FORMULATIONS OF GLYCYL-2-METHYLPROLYL-GLUTAMATE
IL202765A0 (en) Pharmaceutical combination of nsaid and prostaglandin compound
EP2152232A4 (en) METHOD AND COMPOSITIONS FOR OXYBUTYNINE ADMINISTRATION
ZA200900230B (en) 4-hydroxythiobenzamide derivatives of drugs
EP2222328A4 (en) PROCESS FOR THE ADMINISTRATION OF CONJUGATES
EP2037952A4 (en) ADMINISTRATION OF ERYTHROPOIETIN BY INJECTION IN GLASS
IL196320A0 (en) Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
IL202766A0 (en) Pharmaceutical combination of opioid and prostaglandin compound
HK1131039A1 (en) Pharmaceutical use of sophoricoside
EP2175918A4 (en) MANUFACTURE OF COMPONENTS OF MEDICAL DISTRIBUTORS
EP2098245A4 (en) USE OF CHOLINESTERASE FOR THE PREPARATION OF ANTI-TACHYKININ MEDICAMENT
GB0610207D0 (en) New forms of active pharmaceutical ingredient
GB0619891D0 (en) Pharmaceutical composition of risedronate
EP1993591A4 (en) TARGETED RELEASE OF PHARMACEUTICAL COMPOUNDS
ZA200806439B (en) Stable dosage formulations of imidazolylalkyl-pyridines
ZA200810632B (en) Derivativs and analogs of N-ethylquinolones and N-ethylazaquinolones